(Q45875775)

17 December 2017

title

Expression-targeted gene therapy for the treatment of transitional cell carcinoma (English)

1 reference

17 December 2017

0 references

2

1 reference

17 December 2017

author name string

X Zhang

series ordinal

1

1 reference

17 December 2017

W T Godbey

series ordinal

3

1 reference

17 December 2017

publication date

7 March 2008

1 reference

17 December 2017

published in

Cancer Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

page(s)

543-552

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/cgt.2008.7

exact match

0 references

cites work

Cell-specific expression of SERCA, the exogenous Ca2+transport ATPase, in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancers

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

COX-2 and Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Expression of cyclooxygenase-1 and -2 in urinary bladder carcinomas in vivo and in vitro and prostaglandin E2 synthesis in cultured bladder cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Expression of cyclooxygenase-2 in patients with bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Comparison of caspase genes for the induction of apoptosis following gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Transduction of Apaf-1 or caspase-9 induces apoptosis in A-172 cells that are resistant to p53-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Improved artificial death switches based on caspases and FADD.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Redesigning an FKBP-ligand interface to generate chemical dimerizers with novel specificity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

A mechanistic role for cardiac myocyte apoptosis in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Conditional cell ablation by tight control of caspase-3 dimerization in transgenic mice.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Directed apoptosis in Cox-2-overexpressing cancer cells through expression-targeted gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Molecular cloning and sequence analysis of a mouse Y chromosome RNA transcript expressed in the testis

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Expression of cyclooxygenase-2 in Hodgkin's lymphoma: its role in cell proliferation and angiogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

AdCD40L gene therapy counteracts T regulatory cells and cures aggressive tumors in an orthotopic bladder cancer model

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.7

7 January 2021

Identifiers

DOI

10.1038/CGT.2008.7

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017